Universitätsklinikum Ulm


Standort der Organisation:
Ulm, Deutschland

Forschungsprojekte mit FAU-Wissenschaftlern

Guter Start ins Kinderleben
Dr. Ina Bovenschen; Prof. Dr. Dr. Gottfried Spangler

Publikationen in Kooperation mit FAU-Wissenschaftern

Go to first page Go to previous page 1 von 6 Go to next page Go to last page
Arnold, M., Bach, C., Heinemann, F.M., Horn, P.A., Ziemann, M., Lachmann, N.,... Spriewald, B.M. (2018). Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival. International Journal of Immunogenetics. https://dx.doi.org/10.1111/iji.12363
Weis, J., Hoenig, K., Bergelt, C., Faller, H.H., Brechtel, A., Hornemann, B.,... Büttner-Teleaga, A. (2018). Psychosocial distress and utilization of professional psychological care in cancer patients: An observational study in National Comprehensive Cancer Centers (CCCs) in Germany. Psycho-Oncology, 27(12), 2847-2854. https://dx.doi.org/10.1002/pon.4901
Loibl, S., Weber, K., Huober, J., Krappmann, K., Marme, F., Schem, C.,... Denkert, C. (2018). Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor. Clinical Cancer Research, 24(14), 3358-3365. https://dx.doi.org/10.1158/1078-0432.CCR-17-2947
Mathew, N.R., Baumgartner, F., Braun, L., O'Sullivan, D., Thomas, S., Waterhouse, M.,... Zeiser, R. (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature Medicine. https://dx.doi.org/10.1038/nm.4484
Gaß, P., Untch, M., Mueller, V., Moebus, V., Thomssen, C., Häberle, L.,... Nabieva, N. (2018). Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians. Geburtshilfe und Frauenheilkunde, 78(7), 707-714. https://dx.doi.org/10.1055/a-0642-9462
Freudenmann, R.W., Freudenmann, N., Zurowski, B., Schönfeldt-Lecuona, C., Maier, L., Schmieder, R.,... Gahr, M. (2017). Arterial Hyper- and Hypotension associated with psychiatric medications: a risk assessment based on the summaries of product characteristics (SmPCs). Deutsche Medizinische Wochenschrift. https://dx.doi.org/10.1055/s-0043-111739
Ripperger, T., Bielack, S.S., Borkhardt, A., Brecht, I.B., Burkhardt, B., Calaminus, G.,... Kratz, C.P. (2017). Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. American Journal of Medical Genetics Part A, 173(4), 1017-1037. https://dx.doi.org/10.1002/ajmg.a.38142
Stößel, A., Brox, R., Purkayastha, N., Hübner, H., Hocke, C., Prante, O., & Gmeiner, P. (2017). Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior. Bioorganic & Medicinal Chemistry, 25(13), 3491-3499. https://dx.doi.org/10.1016/j.bmc.2017.04.036
Kriegmayr, M., Bergen, T., Ritter, M., Mandel, P., Michel, M., Wittenberg, T., & Bolenz, C. (2017). Digital Mapping of the Urinary Bladder: Potential for Standardized Cystoscopy Reports. Urology, 104(104), 235-241. https://dx.doi.org/10.1016/j.urology.2017.02.019
Nitz, U., Gluz, O., Huober, J., Kreipe, H.H., Kates, R.E., Hartmann, A.,... Kuhn, W. (2017). Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014). Annals of Oncology, 28(11), 2899-2899. https://dx.doi.org/10.1093/annonc/mdw349
Hein, A., Rack, B., Li, L., Ekici, A.B., Reis, A., Lux, M.P.,... Haeberle, L. (2017). Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study. Geburtshilfe und Frauenheilkunde, 77(6), 651-659. https://dx.doi.org/10.1055/s-0042-113189
Riener, M.-O., Hoegel, J., Iro, H., Hartmann, A., & Agaimy, A. (2017). IMP3 and p16 expression in squamous cell carcinoma of the head and neck: A comparative immunohistochemical analysis. Oncology Letters, 14(2), 1665-1670. https://dx.doi.org/10.3892/ol.2017.6352
Wallwiener, M., Heindl, F., Brucker, S.Y., Taran, F.-A., Hartkopf, A., Overkamp, F.,... Gaß, P. (2017). Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry. Geburtshilfe und Frauenheilkunde, 77(8), 870-878. https://dx.doi.org/10.1055/s-0043-116223
Loos, S., Aulbert, W., Hoppe, B., Ahlenstiel-Grunow, T., Kranz, B., Wahl, C.,... Kemper, M.J. (2017). Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4. Clinical Infectious Diseases, 64(12), 1637-1643. https://dx.doi.org/10.1093/cid/cix218
Zierk, J., Arzideh, F., Haeckel, R., Cario, H., Fruehwald, M.C., Gross, H.-J.,... Rauh, M. (2017). Pediatric reference intervals for alkaline phosphatase. Clinical Chemistry and Laboratory Medicine, 55(1), 102-110. https://dx.doi.org/10.1515/cclm-2016-0318
Einsele, H., Engelhardt, M., Tapprich, C., Mueller, J., Liebisch, P., Langer, C.,... Knop, S. (2017). Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial. British Journal of Haematology, 179(4), 586-597. https://dx.doi.org/10.1111/bjh.14920
Lehmer, C., Oeckl, P., Weishaupt, J.H., Volk, A.E., Diehl-Schmid, J., Schroeter, M.L.,... Otto, M. (2017). Poly-GP in cerebrospinal fluid linksC9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD. Embo Molecular Medicine, 9(7), 859-868. https://dx.doi.org/10.15252/emmm.201607486
Heppt, M., Heinzerling, L., Kaehler, K., Forschner, A., Kirchberger, M., Loquai, C.,... Berking, C. (2017). Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition. (pp. 14-14).
Zengerling, F., Kunath, F., Jensen, K., Ruf, C., Schmidt, S., & Spek, A. (2017). Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance-A systematic review. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2017.06.047
Einsele, H., Knop, S., Vogel, M., Mueller, J., Kropff, M., Metzner, B.,... Straka, C. (2017). Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma. Leukemia. https://dx.doi.org/10.1038/leu.2017.83

Zuletzt aktualisiert 2016-15-06 um 08:31